KIMMTRAK 100 ug/.5mL
TEBENTAFUSP · INJECTION, SOLUTION, CONCENTRATE · Immunocore Commercial LLC
KIMMTRAK is a injection, solution, concentrate containing tebentafusp at 100 ug/.5mL, taken intravenous. Manufactured by Immunocore Commercial LLC.
Key Facts
- Brand Name
- KIMMTRAK
- Generic Name
- TEBENTAFUSP
- NDC Code (Product)
80446-401- Manufacturer
- Immunocore Commercial LLC
- Strength
- 100 ug/.5mL
- Dosage Form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761228
- Drug Class
- Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]
- Marketing Start
- 01/26/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is KIMMTRAK used for?
KIMMTRAK contains TEBENTAFUSP. It is a injection, solution, concentrate taken intravenous. Consult your doctor for specific uses.
Is KIMMTRAK a controlled substance?
KIMMTRAK is not classified as a controlled substance by the DEA.
What is the generic name for KIMMTRAK?
The generic name for KIMMTRAK is TEBENTAFUSP. There are no other listed brand versions of TEBENTAFUSP.
What is the NDC code for KIMMTRAK 100 ug/.5mL?
The NDC (National Drug Code) for KIMMTRAK 100 ug/.5mL is 80446-401, listed by Immunocore Commercial LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)